NW-301D

DRUG3 trials

Sponsors

TingBo Liang, Tao Zhang, Ting Deng

Conditions

Tumor, Solid

Phase 1

T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

RecruitingNCT06478251

TingBo LiangTumor, Solid

Start: 2024-02-01End: 2027-06-30Target: 9Updated: 2025-11-25

T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

RecruitingNCT06484556

Tao ZhangTumor, Solid

Start: 2024-06-19End: 2027-06-30Target: 9Updated: 2025-07-31

T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

RecruitingNCT06484790

Ting DengTumor, Solid

Start: 2024-04-08End: 2027-04-07Target: 9Updated: 2025-11-25